NTX-301

Near Add Your Location

Accepting patients

NTX-301

A Phase 1 Study of NTX-301, an Oral DNMT1 Inhibitor, in Patients With MDS and AML
Learn more
  • DNMT1 Inhibitor
  • Phase 1